Roth Capital Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $12

Benzinga Newsdesk www.benzinga.com Neutral 59.4%

Neg 0% Neu 59.4% Pos 0%

Roth Capital analyst Adam Walsh initiates coverage on Equillium (NASDAQ:EQ) with a Buy rating and announces Price Target of $12.